Open Payments, the national disclosure program from CMS, promotes transparency into financial relationships between pharmaceutical/medical device companies and health care professionals, including physicians. The program offers health care professionals an opportunity to review, affirm and, if necessary, dispute payments attributed to them by these companies before they are made public by June 30. The pre-publication review and dispute period began April 1 and ends May 15.

Open Payments encourages all covered physicians to review the reported data to ensure the information is accurate before it is published. Get started by registering here and learn more at OpenPaymentsData.cms.gov.